BCV
CORZ icon

Banque Cantonale Vaudoise’s Core Scientific CORZ Stock Holding History

Banque Cantonale Vaudoise’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,000
Closed -$28K – 801
2024
Q2 		$28K Buy
+3,000
New +$15.3K ﹤0.01% 856

Other funds holding CORZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OWP
ORG Wealth Partners Dallas, Texas $668M AUM 45.71% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $849M AUM 28.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
JCM
JAT Capital Management Greenwich, Connecticut $59.3M AUM 134.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Banque Cantonale Vaudoise's CORZ Position: Q3 2024 in Review

Banque Cantonale Vaudoise sold out of Core Scientific (CORZ) in Q3 2024, closing a stake of 3,000 shares — an estimated $28K sold.

Banque Cantonale Vaudoise first reported a position in CORZ in Q2 2024 and held it in 1 quarter. The position peaked at $28K in Q2 2024. 249 funds tracked by Wall St. Rank hold CORZ as of Q3 2024.

  • Banque Cantonale Vaudoise reported no remaining Core Scientific position as of Q3 2024 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 3,000 Core Scientific shares in Q3 2024, an estimated $28K.
  • Banque Cantonale Vaudoise first reported a position in Core Scientific in Q2 2024 and held it in 1 quarter.
  • Banque Cantonale Vaudoise's Core Scientific position peaked at $28K in Q2 2024.
  • 249 funds tracked by Wall St. Rank held Core Scientific as of Q3 2024.

Based on Banque Cantonale Vaudoise's 13F filing for Q3 2024, filed 8 Nov 2024.